Kronos Bio Inc (KRON) — Financial Flexibility Index

Latest as of March 2025: -0.45x

Kronos Bio Inc (KRON) has a Financial Flexibility Index of -0.45x as of March 2025. Free cash flow of $-12.84 Million (operating CF $-12.84 Million minus capex $4.00K) represents 0% of total liabilities ($28.33 Million). Check tangible net worth ratio of Kronos Bio Inc to evaluate the tangible quality of the company's equity base.

Financial Flexibility Index

-0.45x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-12.84 Million
Operating CF − Capex

Total Liabilities

$28.33 Million
USD

Capital Expenditures

$4.00K
USD

Kronos Bio Inc Financial Flexibility Index (2018–2024)

Historical Financial Flexibility Index trend for Kronos Bio Inc across 7 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Kronos Bio Inc.

Annual Financial Flexibility Index for Kronos Bio Inc (2018–2024)

Year-by-year free cash flow to debt coverage for Kronos Bio Inc. Explore cash flow to debt ratio of Kronos Bio Inc to assess how comfortably operating cash covers total debt obligations.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -1.78x $-65.43 Million $-65.44 Million $36.78 Million ▼ -23.8%
2023 -1.44x $-77.90 Million $-78.58 Million $54.20 Million ▲ +19.8%
2022 -1.79x $-90.35 Million $-90.93 Million $50.44 Million ▲ +26.9%
2021 -2.45x $-113.66 Million $-117.92 Million $46.38 Million ▼ -301.6%
2020 -0.61x $-28.34 Million $-37.91 Million $46.45 Million ▼ -533.1%
2019 -0.10x $-12.13 Million $-15.08 Million $125.89 Million ▲ +64.2%
2018 -0.27x $-5.37 Million $-6.44 Million $19.91 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities